Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer
about
CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinantIdentification of ERF-1 as a member of the AP2 transcription factor familyPositional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinomaComprehensive genome sequence analysis of a breast cancer ampliconEnd-sequence profiling: sequence-based analysis of aberrant genomesDifferentially regulated genes as putative targets of amplifications at 20q in ovarian cancersA homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersRole of protein tyrosine phosphatases in cancerDNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma.AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.Decoding the fine-scale structure of a breast cancer genome and transcriptome.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisDynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice.DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.Molecular cytogenetic analysis of 11 new breast cancer cell linesEpithelial protein-tyrosine phosphatase 1B contributes to the induction of mammary tumors by HER2/Neu but is not essential for tumor maintenance.Characterization of ASC-2 as an antiatherogenic transcriptional coactivator of liver X receptors in macrophagesAssociation of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells.Genomic signatures of breast cancer metastasis.A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB.
P2860
Q24290613-2CBEB513-47FD-492A-9AC4-830F03B86449Q24314887-8B8ED1BC-D2E4-4434-9012-94D30DC7C6C7Q24317037-F9AF472E-9F28-4613-9F7B-5B097F377065Q24618889-8F31B305-15D3-4096-9C3E-7B92426AD9EBQ24670275-E79D44BB-7F3D-4FE7-81CA-2F2123B1DC65Q28213364-E92E90CB-506A-4E46-BE31-1D35D414EFF7Q28272347-B789A3A4-9C53-405D-92B1-FCDDCA43667DQ28741003-9C38FF0C-E83A-4C93-A11C-6FE2D29FEE43Q30693246-CC50D13D-E1C6-44EA-9D3F-D85762875E5DQ33241980-32D0239A-A8E4-4AB9-A196-BA42AD237694Q33260375-CA0E9DED-C490-415A-96B5-FFCB384FBE3CQ34386622-4293463C-920A-490E-9D88-77774D38A2D4Q34483093-AC9B04A5-C29D-4DA6-B89C-DB1BA1A78500Q34493341-D78B4197-3943-4B2D-B8FD-FB1A36C5F388Q34596358-8D7DD0FA-B27C-497E-8F57-139374AC9894Q34980453-C97E3CDA-4C04-4D72-8100-EDDB5A1CB980Q35148589-3D8AC412-3CE0-4AEA-BF70-9878ED0EC766Q35765428-AD61108B-D629-4926-A08B-FCD7D450304CQ35787051-0944D52C-C4B1-4626-AD58-4D169A1CFFDBQ35809752-28BFE958-903E-4929-87FF-BDD42ED53FF1Q36619975-AB564A6C-CCD1-40E9-97B3-4B6A82D8A389Q36634268-C743DF14-0EDC-4CB0-B7AD-9F5379E4AF5BQ37244859-94EC45BA-030B-42D6-8CC4-5A57771B638CQ37397626-B1CA01A9-4F9D-4181-A296-7E28696B6A02Q37413146-6661DA67-A383-45DE-9226-1F956DCA1B43Q42164683-371BF2FA-5E55-4123-8FFC-110D7128952BQ42259243-7D37579F-7101-492F-8D5F-4F0F4608E4A1Q55217356-CFAB067D-F925-4466-B218-0D1B861B3D7D
P2860
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Independent amplification and ...... some 20 in human breast cancer
@ast
Independent amplification and ...... some 20 in human breast cancer
@en
Independent amplification and ...... some 20 in human breast cancer
@nl
type
label
Independent amplification and ...... some 20 in human breast cancer
@ast
Independent amplification and ...... some 20 in human breast cancer
@en
Independent amplification and ...... some 20 in human breast cancer
@nl
prefLabel
Independent amplification and ...... some 20 in human breast cancer
@ast
Independent amplification and ...... some 20 in human breast cancer
@en
Independent amplification and ...... some 20 in human breast cancer
@nl
P2093
P3181
P1433
P1476
Independent amplification and ...... some 20 in human breast cancer
@en
P2093
A Kallioniemi
M M Tanner
M Tirkkonen
T Kuukasjärvi
P304
P3181
P407
P577
1996-08-01T00:00:00Z